Chaperone-mediated destruction of erbB2: relevance to tyrosine kinase inhibitors.
Gee
Julia M W
JM
Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff University, Wales, UK.
D001943:Breast Neoplasms / Q000378:metabolism* / Q000628:therapy; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D018841:HSP90 Heat-Shock Proteins / Q000378:metabolism*; D006801:Humans; D021381:Protein Transport / Q000187:drug effects / Q000502:physiology; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism*; D015398:Signal Transduction
D004791:Enzyme Inhibitors; D018841:HSP90 Heat-Shock Proteins; D011505:Protein-Tyrosine Kinases; D018719:Erb-b2 Receptor Tyrosine Kinases